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UTTER TO THE EDI TOR
Breast Cancer and Screening in Hong
Kong
Dear Editor,
The articles by Lam et al] and Dixon2 reflect the
current problem with screening in many areas of
contemporary medical practice. This is the mis-
appropriation of screening procedures, in the context of
routine health care services without proper regard for
the factors which determine whether or not the screening
tool is effective and whether it is likely to lead to
measureable health gains. The fact that the incidence of
breast cancer in Hong Kong is much lower than in
Western countries deserves greater emphasis. The three
fold difference between a 1 in 27 chance of having the
disease in Hong Kong women, compared with a ratio of
1 in 8 in the US immediately indicates that the positive
predictive value of any test will be lower in this
environment than elsewhere.
Although the overall burden of the problem will
increase because of the ageing population, in Hong
Kong there is no evidence of a convincing rising trend,
at least not in the age group which might benefit from
screening. There are approximately 300 deaths per
annum to be prevented occurring in 1.7 million women
aged 20 to 70+ years. However if screening confers any
benefit this is only available to some of th'e 442,000
women aged 50-69. They contributed only 129 (39%) of
the 330 deaths which occurred in 1991. Assuming the
same prevalence at screening as in Western women,
according to the analysis of Wright and Mueller
screening of women in this age group in Hong Kong,
over 7 years, would yield 66,300 positive tests of which
57,217 would be false positives. The deaths occurring
in this group would total 486 compared with 663 if they
were unscreened, yielding 177 avoided deaths at a cost
of HK$ 1.239 billion. As Dixon points out, 18,000
women would have to be screened per death avoided,
but we must also note that 2,700 of these would have
false positive results. Put another way, only 177 out of
the 442,000 women (0.04%) would benefit. Finally we
should acknowledge that the screening, if it conformed
rigorously to the procedures and standards maintained
in the best performing trials, would only prevent 20%
of the deaths in the age group 50-69. This amounts to
only 8% of all breast cancer deaths in the Territory.
Furthermore we can expect the total mortality in women
screened for breast cancer to be the same as for
unscreened women.
So there is, in our view, no point in allocating
resources of this order to an intervention of unproven
effectiveness and cost effectiveness in the Territory.
A more rewarding health care activity would be to
identify and implement effective interventions to
prevent the recruitment of children and young women to
smoking in Hong Kong. This, by contrast, would yield
unquestionable benefits for population health far in
excess of the predictable outcome (at present) of
attempting to reduce breast cancer mortality through
mass mammography.
It is unlikely that most of the questions raised by the
present uncertainties about screening will be answered
in this region without well designed randomised
controlled trials in defined populations. Singapore is
planning such a trial. Future trials should include the
exploration of different approaches to the recruitment of
women in defined at risk populations, in addition to
questions relating to the effectiveness of the screening
procedure itself. |
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